These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 33300115)

  • 21. Ocular and visual disorders in Parkinson's disease: Common but frequently overlooked.
    Ekker MS; Janssen S; Seppi K; Poewe W; de Vries NM; Theelen T; Nonnekes J; Bloem BR
    Parkinsonism Relat Disord; 2017 Jul; 40():1-10. PubMed ID: 28284903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Myasthenia gravis and elderly persons. A case study].
    Saraux-Bonneton A; Raffin B; Vautier F; Laudet J
    Rev Med Interne; 2001 Oct; 22(10):984-7. PubMed ID: 11695322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency and Characteristics of Psychosis in Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Chendo I; Silva C; Duarte GS; Prada L; Voon V; Ferreira JJ
    J Parkinsons Dis; 2022; 12(1):85-94. PubMed ID: 34806620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extraocular muscle surgery in myasthenia gravis.
    Acheson JF; Elston JS; Lee JP; Fells P
    Br J Ophthalmol; 1991 Apr; 75(4):232-5. PubMed ID: 2021593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment for diplopia in patients with myasthenia gravis.
    Park KA; Oh SY
    Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):895-901. PubMed ID: 23275035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of dementia and visual hallucinations in tremor and non-tremor dominant Parkinson's disease.
    Rana AQ; Vaid HM; Edun A; Dogu O; Rana MA
    J Neurol Sci; 2012 Dec; 323(1-2):158-61. PubMed ID: 23062324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hallucinations in Parkinson's disease: cross-sectional study.
    Svetel M; Smiljković T; Pekmezović T; Kostić V
    Acta Neurol Belg; 2012 Mar; 112(1):33-7. PubMed ID: 22427287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Visual Dysfunction in Patients with Parkinson's Disease.
    Savitt J; Aouchiche R
    J Parkinsons Dis; 2020; 10(s1):S49-S56. PubMed ID: 32741840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive identification of delusions and olfactory, tactile, gustatory, and minor hallucinations in Parkinson's disease psychosis.
    Kulick CV; Montgomery KM; Nirenberg MJ
    Parkinsonism Relat Disord; 2018 Sep; 54():40-45. PubMed ID: 29653909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease.
    Llebaria G; Pagonabarraga J; Martínez-Corral M; García-Sánchez C; Pascual-Sedano B; Gironell A; Kulisevsky J
    Mov Disord; 2010 Dec; 25(16):2785-91. PubMed ID: 20960483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for hallucinations in Parkinson's disease: results from a large prospective cohort study.
    Zhu K; van Hilten JJ; Putter H; Marinus J
    Mov Disord; 2013 Jun; 28(6):755-62. PubMed ID: 23520046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of Cannabis on hallucinations in Parkinson's disease patients.
    Cravanas B; Frei K
    J Neurol Sci; 2020 Dec; 419():117206. PubMed ID: 33161300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case Report: Ocular Myasthenia Gravis Associated with In Vitro Fertilization Procedures.
    Yoo YJ; Han SB; Yang HK; Hwang JM
    Optom Vis Sci; 2018 May; 95(5):475-478. PubMed ID: 29683988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with drug-induced visual hallucinations in Parkinson's disease.
    Papapetropoulos S; Argyriou AA; Ellul J
    J Neurol; 2005 Oct; 252(10):1223-8. PubMed ID: 15834642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of visual hallucinations in dementia and Parkinson's disease.
    Swann P; O'Brien JT
    Int Psychogeriatr; 2019 Jun; 31(6):815-836. PubMed ID: 30398127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sleep disturbances in Taiwanese patients with Parkinson's disease.
    Lin YY; Chen RS; Lu CS; Huang YZ; Weng YH; Yeh TH; Lin WY; Hung J
    Brain Behav; 2017 Oct; 7(10):e00806. PubMed ID: 29075566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.
    Goldman JG; Stebbins GT; Dinh V; Bernard B; Merkitch D; deToledo-Morrell L; Goetz CG
    Brain; 2014 Mar; 137(Pt 3):849-59. PubMed ID: 24480486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and Risk Factors for Minor Hallucinations in Patients with Parkinson's Disease.
    Zhong M; Gu R; Zhu S; Bai Y; Wu Z; Jiang X; Shen B; Zhu J; Pan Y; Yan J; Zhang L
    Behav Neurol; 2021; 2021():3469706. PubMed ID: 34646400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.
    Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M
    J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Parkinson's Disease in the Oldest-Old].
    Kimpara T; Takeda A
    Brain Nerve; 2020 Dec; 72(12):1345-1352. PubMed ID: 33293468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.